search
Back to results

TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study

Primary Purpose

Lumbar Degenerative Disc Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TRIUMPH® Lumbar Artificial Disc
Sponsored by
Globus Medical Inc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lumbar Degenerative Disc Disease focused on measuring Low back pain, Leg pain, Discogenic pain, Degenerative Disc Disease (DDD), Herniated disc, Radiculopathy

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Degenerative Disc Disease in one vertebral level between L1 and S1
  • Able to understand and sign informed consent
  • Had at least 6 months of conservative treatment
  • Oswestry Disability Index Score of at least 30 (one a 100 point scale)
  • Other inclusion criteria as specified in approved IDE protocol

Exclusion Criteria:

  • Bilateral leg pain
  • Back or leg pain of unknown etiology
  • Prior fusion surgery or another spinal device implanted at any other lumbar level
  • Osteoporosis or osteopenia
  • Other exclusion criteria as specified in approved IDE protocol

Sites / Locations

  • Memorial Health University Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

TRIUMPH® Artificial Disc

Arm Description

Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).

Outcomes

Primary Outcome Measures

Number of Participants With a Change of at Least 15 Points in Pain/Disability Using the Oswestry Disability Index (ODI) Score at 24 Months Compared With the Score at Baseline
The Oswestry Disability Index (ODI) is a commonly used outcome-measure questionnaire for low back pain in a hospital setting. It is a self-administered questionnaire divided into ten sections designed to assess limitations of various activities of daily living. Each section is scored on a 0-5 scale, 5 representing the greatest disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
Number of Participants With No Device Failures
Any device requiring surgical revision, reoperation, removal or supplemental fixation will be considered a device failure
Number of Participants With Major Complications Defined as Major Vessel Injury or Neurological Damage
Major vessel injury is defined as injury of the aorta or vena cava or other major vessels (e.g. iliac arteries, superior rectal artery, iliac veins, and their branches), caused by the surgery or device, resulting in significant blood loss or requiring additional surgery to correct. Neurological damage is defined as damage to the spinal cord or a nerve root caused by the surgery or device, resulting in neurologic deficit that persists for more than 3 months and is without improvement, is progressive, or involves motor loss. Major complications are reported on adverse event case report forms.
Number of Participants Determined to Have a Normal Neurological Status
Neurological status was assessed using a neurological status scale, which is based on four types of measurement parameters: motor, sensory, reflexes, and straight leg raise. The method for summarizing neurological status is described below. Each parameter (i.e. motor, sensory, reflexes, straight leg raise) is coded as follows: Motor 0 Total Paralysis Palpable or Visible Contraction Active Movement, Gravity Eliminated Active Movement, Against Gravity Active Movement, Against Some Resistance Active Movement, Against Full Resistance Sensory 0 Absent Impaired Normal Reflexes 0 Absent or Trace Hyper-reflexive Normal or hypo-reflexive Straight Leg Raise 0 0° - 70° (Abnormal) 1 > 70°-90° (Normal) If all evaluations for the parameter are determined to be normal, then the parameter is given a normal status. If any evaluations for the parameter are abnormal, then the parameter is given an abnormal status.

Secondary Outcome Measures

Full Information

First Posted
September 8, 2010
Last Updated
October 1, 2018
Sponsor
Globus Medical Inc
search

1. Study Identification

Unique Protocol Identification Number
NCT01198470
Brief Title
TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study
Official Title
A Prospective Clinical Investigation of the TRIUMPH Lumbar Disc: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
September 2010 (undefined)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
December 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Globus Medical Inc

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this investigation is to evaluate the safety and effectiveness of the TRIUMPH® Lumbar Artificial Disc for the treatment of patients who are suffering from Degenerative Disc Disease (DDD) at one level from L1 to S1.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Degenerative Disc Disease
Keywords
Low back pain, Leg pain, Discogenic pain, Degenerative Disc Disease (DDD), Herniated disc, Radiculopathy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TRIUMPH® Artificial Disc
Arm Type
Experimental
Arm Description
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc. This is a non-randomized pilot study with only one arm (no control).
Intervention Type
Device
Intervention Name(s)
TRIUMPH® Lumbar Artificial Disc
Intervention Description
The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
Primary Outcome Measure Information:
Title
Number of Participants With a Change of at Least 15 Points in Pain/Disability Using the Oswestry Disability Index (ODI) Score at 24 Months Compared With the Score at Baseline
Description
The Oswestry Disability Index (ODI) is a commonly used outcome-measure questionnaire for low back pain in a hospital setting. It is a self-administered questionnaire divided into ten sections designed to assess limitations of various activities of daily living. Each section is scored on a 0-5 scale, 5 representing the greatest disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
Time Frame
24 months
Title
Number of Participants With No Device Failures
Description
Any device requiring surgical revision, reoperation, removal or supplemental fixation will be considered a device failure
Time Frame
24 months
Title
Number of Participants With Major Complications Defined as Major Vessel Injury or Neurological Damage
Description
Major vessel injury is defined as injury of the aorta or vena cava or other major vessels (e.g. iliac arteries, superior rectal artery, iliac veins, and their branches), caused by the surgery or device, resulting in significant blood loss or requiring additional surgery to correct. Neurological damage is defined as damage to the spinal cord or a nerve root caused by the surgery or device, resulting in neurologic deficit that persists for more than 3 months and is without improvement, is progressive, or involves motor loss. Major complications are reported on adverse event case report forms.
Time Frame
24 months
Title
Number of Participants Determined to Have a Normal Neurological Status
Description
Neurological status was assessed using a neurological status scale, which is based on four types of measurement parameters: motor, sensory, reflexes, and straight leg raise. The method for summarizing neurological status is described below. Each parameter (i.e. motor, sensory, reflexes, straight leg raise) is coded as follows: Motor 0 Total Paralysis Palpable or Visible Contraction Active Movement, Gravity Eliminated Active Movement, Against Gravity Active Movement, Against Some Resistance Active Movement, Against Full Resistance Sensory 0 Absent Impaired Normal Reflexes 0 Absent or Trace Hyper-reflexive Normal or hypo-reflexive Straight Leg Raise 0 0° - 70° (Abnormal) 1 > 70°-90° (Normal) If all evaluations for the parameter are determined to be normal, then the parameter is given a normal status. If any evaluations for the parameter are abnormal, then the parameter is given an abnormal status.
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Degenerative Disc Disease in one vertebral level between L1 and S1 Able to understand and sign informed consent Had at least 6 months of conservative treatment Oswestry Disability Index Score of at least 30 (one a 100 point scale) Other inclusion criteria as specified in approved IDE protocol Exclusion Criteria: Bilateral leg pain Back or leg pain of unknown etiology Prior fusion surgery or another spinal device implanted at any other lumbar level Osteoporosis or osteopenia Other exclusion criteria as specified in approved IDE protocol
Facility Information:
Facility Name
Memorial Health University Medical Center
City
Savannah
State/Province
Georgia
ZIP/Postal Code
31403
Country
United States

12. IPD Sharing Statement

Learn more about this trial

TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study

We'll reach out to this number within 24 hrs